Ahn-Gook Pharmaceutical (A001540) Stock Overview
Manufactures and sells pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
A001540 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Ahn-Gook Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩11,360.00 |
| 52 Week High | ₩12,730.00 |
| 52 Week Low | ₩7,280.00 |
| Beta | 0.77 |
| 1 Month Change | 44.71% |
| 3 Month Change | 43.25% |
| 1 Year Change | 44.16% |
| 3 Year Change | 40.25% |
| 5 Year Change | -18.86% |
| Change since IPO | 5.76% |
Recent News & Updates
Some May Be Optimistic About Ahn-Gook Pharmaceutical's (KOSDAQ:001540) Earnings
The market for Ahn-Gook Pharmaceutical Co., Ltd.'s ( KOSDAQ:001540 ) shares didn't move much after it posted weak...Earnings Working Against Ahn-Gook Pharmaceutical Co., Ltd.'s (KOSDAQ:001540) Share Price
When close to half the companies in Korea have price-to-earnings ratios (or "P/E's") above 14x, you may consider...Recent updates
Shareholder Returns
| A001540 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -0.09% | -3.5% | -0.3% |
| 1Y | 44.2% | 4.8% | 165.0% |
Return vs Industry: A001540 exceeded the KR Pharmaceuticals industry which returned 2.2% over the past year.
Return vs Market: A001540 underperformed the KR Market which returned 150.4% over the past year.
Price Volatility
| A001540 volatility | |
|---|---|
| A001540 Average Weekly Movement | 10.1% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in KR Market | 16.1% |
| 10% least volatile stocks in KR Market | 4.4% |
Stable Share Price: A001540 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A001540's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 391 | June-Sun Auh | www.ahn-gook.com |
Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.
Ahn-Gook Pharmaceutical Co., Ltd. Fundamentals Summary
| A001540 fundamental statistics | |
|---|---|
| Market cap | ₩129.11b |
| Earnings (TTM) | ₩16.27b |
| Revenue (TTM) | ₩330.05b |
Is A001540 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A001540 income statement (TTM) | |
|---|---|
| Revenue | ₩330.05b |
| Cost of Revenue | ₩111.92b |
| Gross Profit | ₩218.13b |
| Other Expenses | ₩201.86b |
| Earnings | ₩16.27b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.43k |
| Gross Margin | 66.09% |
| Net Profit Margin | 4.93% |
| Debt/Equity Ratio | 45.4% |
How did A001540 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/12 17:05 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ahn-Gook Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Min-young Lee | Korea Investment & Securities Co., Ltd. |